Back to Journals » International Journal of Nephrology and Renovascular Disease » Volume 14
Retraction
Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
2,955 | Dovepress* | 2,701+ | 459 | 3,160 | |
PubMed Central* | 254 | 33 | 287 | ||
Totals | 2,955 | 492 | 3,447 | ||
*Since 3 March 2021 |
View citations on PubMed Central and Google Scholar